PLGA-PEG nanoparticles have been used to encapsulate circRNA inhibitors, protecting them from enzymatic degradation and improving tumor accumulation in gastric cancer models, where they successfully reduced PD-L1 expression and enhanced T cell–mediated killing. The gene discussed is CD274; the disease is neoplasm.